Insider Transactions in Q3 2021 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 23
2021
|
Dominic Smethurst Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$108,000
$18.55 P/Share
|
Sep 16
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,955
-36.74%
|
$87,975
$45.01 P/Share
|
Sep 15
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-36.05%
|
$135,000
$45.0 P/Share
|
Sep 02
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-54.58%
|
$400,000
$40.0 P/Share
|
Sep 02
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$400,000
$40.0 P/Share
|
Sep 02
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$90,000
$9.82 P/Share
|
Sep 02
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-2.08%
|
$200,000
$40.0 P/Share
|
Sep 01
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,085
-3.47%
|
$1,002,145
$37.33 P/Share
|
Sep 01
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,890
+7.89%
|
$320,460
$14.0 P/Share
|
Aug 31
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,225
-2.21%
|
$404,100
$36.66 P/Share
|
Aug 31
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,420
+3.92%
|
$145,880
$14.0 P/Share
|
Aug 27
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,808
-0.73%
|
$65,088
$36.02 P/Share
|
Aug 27
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,808
+0.73%
|
$25,312
$14.0 P/Share
|
Aug 27
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
7,950
-100.0%
|
$278,250
$35.15 P/Share
|
Aug 27
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,950
+50.0%
|
$63,600
$8.73 P/Share
|
Aug 26
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
550
-100.0%
|
$19,250
$35.04 P/Share
|
Aug 26
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
550
+50.0%
|
$4,400
$8.76 P/Share
|
Aug 23
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$247,500
$33.02 P/Share
|
Aug 23
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$7,500
$1.6 P/Share
|
Jul 29
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
12,500
-87.8%
|
$400,000
$32.06 P/Share
|
Jul 29
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$12,500
$1.63 P/Share
|
Jul 26
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$3,600
$36.0 P/Share
|
Jul 26
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.04%
|
$1,400
$14.0 P/Share
|
Jul 23
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,782
-1.91%
|
$172,152
$36.02 P/Share
|
Jul 23
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,782
+1.88%
|
$66,948
$14.0 P/Share
|
Jul 16
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
609
-0.25%
|
$20,706
$34.0 P/Share
|
Jul 16
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+0.25%
|
$8,526
$14.0 P/Share
|
Jul 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
21,970
-8.23%
|
$746,980
$34.28 P/Share
|
Jul 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,970
+7.6%
|
$307,580
$14.0 P/Share
|
Jul 14
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-35.31%
|
$350,000
$35.0 P/Share
|
Jul 14
2021
|
Kate Bingham Director |
SELL
Open market or private sale
|
Indirect |
44,295
-2.31%
|
$1,506,030
$34.01 P/Share
|
Jul 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
14,465
-1.41%
|
$491,810
$34.21 P/Share
|
Jul 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,331
+3.11%
|
$116,634
$14.0 P/Share
|
Jul 13
2021
|
Kate Bingham Director |
SELL
Open market or private sale
|
Indirect |
600
-0.03%
|
$19,800
$33.5 P/Share
|
Jul 13
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
38,961
-4.67%
|
$1,285,713
$33.17 P/Share
|
Jul 13
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
35,446
+10.89%
|
$496,244
$14.0 P/Share
|
Jul 13
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
72,701
-97.85%
|
$2,326,432
$32.75 P/Share
|
Jul 13
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
72,701
+29.86%
|
$872,412
$12.28 P/Share
|
Jul 12
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,936
-0.75%
|
$61,952
$32.04 P/Share
|
Jul 12
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+0.75%
|
$27,104
$14.0 P/Share
|
Jul 12
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,028
-100.0%
|
$224,896
$32.03 P/Share
|
Jul 12
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,028
+28.11%
|
$84,336
$12.28 P/Share
|
Jul 06
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
271
-100.0%
|
$8,672
$32.0 P/Share
|
Jul 06
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
271
+50.0%
|
$2,439
$9.82 P/Share
|